Article Details

UPDATE 1-COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in US IPO

Retrieved on: 2021-07-07 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

UPDATE 1-COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in US IPO. View article details on hiswai:

Excerpt

Morgan Stanley, BofA Securities and Jefferies are the lead underwriters for the offering. (Reporting by Niket Nishant in Bengaluru; Editing by Bernard ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up